semaglutide hf in Patients with Heart Failure with Preserved Ejection Fraction and Obesity Clinical Effectiveness and Safety of

Animal experimentation was approved by the Ethic Committee at Spanish Researh National Council (CSIC

Brief room-temperature exposure during handling is different from room-temperature storage

Compounded Medication Notice: Compounded medications referenced in this article are not FDA-approved finished drug products

The compound is currently in Phase 3 evaluation under the TRIUMPH program, which spans registrational trials in obesity, obstructive sleep apnea, and knee osteoarthritis (PMID 41090431)

Used GLP-1 pens should be disposed of according to local NHS guidelines

Older patients may have other health conditions or take medications that could interact with semaglutide